{"eventGroups":[{"deathsNumAffected":2,"deathsNumAtRisk":23,"description":"Patients participate in YST consisting of four 30 minute in-person yoga sessions at weeks 2, 4, 6, and 8 that instructs skills to enhance mindfulness and promote relaxation, through instruction of awareness, movement, breathing practices, and meditation.\n\nLaboratory Biomarker Analysis: Correlative studies\n\nQuestionnaire Administration: Ancillary studies\n\nDaily Survey Administration: Ancillary studies\n\nYoga Skills Training: The YST intervention consists of four 30 minute in-person sessions that instructs skills to enhance mindfulness and promote relaxation. Participants will also be encouraged to practice daily at home.\n\nActigraphy Assessment: Ancillary studies","id":"EG000","otherNumAffected":1,"otherNumAtRisk":23,"seriousNumAffected":4,"seriousNumAtRisk":23,"title":"Group I (Yoga Skills Training)"},{"deathsNumAffected":2,"deathsNumAtRisk":21,"description":"Patients participate in four 30 minute in-person sessions of supportive conversation at weeks 2, 4, 6, 8.\n\nLaboratory Biomarker Analysis: Correlative studies\n\nQuestionnaire Administration: Ancillary studies\n\nDaily Survey Administration: Ancillary studies\n\nAttention Control: The AC intervention consists of four 30 minute in-person sessions of supportive conversation. In addition, the interventionist will recommend that the patients write brief diary entries daily at home.\n\nActigraphy Assessment: Ancillary studies","id":"EG001","otherNumAffected":2,"otherNumAtRisk":21,"seriousNumAffected":3,"seriousNumAtRisk":21,"title":"Group II (Attention Control)"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":23,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":21,"numEvents":1}],"term":"Back pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"CTCAE (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":23,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":21,"numEvents":1}],"term":"Anxiety"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":23,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":21,"numEvents":0}],"term":"Toothache"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE (Unspecified)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":23,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":21,"numEvents":2}],"term":"Death"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":23,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":21,"numEvents":0}],"term":"Bowel perforation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE (Unspecified)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":23,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":21,"numEvents":0}],"term":"Acute kidney injury"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"CTCAE (Unspecified)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":23,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":21,"numEvents":1}],"term":"Bile duct stenosis"}],"timeFrame":"Over 8 weeks"}